Celldex Therapeutics Inc
CLDX22.150USD
-0.040-0.18%
交易中 （美東）報價延遲15分鐘
1.47B總市值
虧損本益比TTM
關於 Celldex Therapeutics Inc 公司
Celldex Therapeutics, Inc. 是一家生物製藥公司。該公司專注於探索肥大細胞生物學科學和爲患者開發變革性療法。其候選藥物包括單克隆抗體和雙特異性抗體，旨在治療現有治療方法不足的肥大細胞介導疾病。其 Barzolvolimab 是一種單克隆抗體，可特異性結合 KIT 受體並有效抑制其活性，該藥物針對多種肥大細胞驅動疾病進行了研究，包括慢性蕁麻疹、結節性癢疹和嗜酸性食管炎。該公司的雙特異性抗體平臺支持管道擴展，並增加針對炎症疾病和腫瘤學的候選藥物。雙特異性平臺包括 CDX-585。CDX-585 結合了其高活性 PD-1 阻斷劑和抗 ILT4 阻斷劑，分別可克服 T 細胞和髓系細胞中的免疫抑制信號。
公司簡介
公司代碼CLDX
公司名稱Celldex Therapeutics Inc
上市日期May 15, 1986
CEOMr. Anthony S. Marucci
員工數量186
證券類型Ordinary Share
年結日May 15
公司地址53 Frontage Road
城市HAMPTON
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編08827
電話19084547120
網址https://celldex.com/
公司代碼CLDX
上市日期May 15, 1986
CEOMr. Anthony S. Marucci
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.64K
+1.48%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
34.14K
+38.79%
Dr. Diane C. Young, M.D.
Dr. Diane C. Young, M.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
17.11K
-63.67%
Dr. Margo Heath-Chiozzi, M.D.
Dr. Margo Heath-Chiozzi, M.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
13.74K
+2.70%
Ms. Elizabeth Crowley
Ms. Elizabeth Crowley
Senior Vice President, Chief Product Development Officer
Senior Vice President, Chief Product Development Officer
9.07K
--
Dr. Tibor Keler, Ph.D.
Dr. Tibor Keler, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
7.36K
--
Mr. Herbert J. (Herb) Conrad
Mr. Herbert J. (Herb) Conrad
Independent Director
Independent Director
2.56K
--
Mr. James J. (Jim) Marino
Mr. James J. (Jim) Marino
Independent Director
Independent Director
2.20K
--
Mr. Keith L. Brownlie, CPA
Mr. Keith L. Brownlie, CPA
Independent Director
Independent Director
666.00
--
Ms. Denice M. Torres, J.D.
Ms. Denice M. Torres, J.D.
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.64K
+1.48%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
34.14K
+38.79%
Dr. Diane C. Young, M.D.
Dr. Diane C. Young, M.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
17.11K
-63.67%
Dr. Margo Heath-Chiozzi, M.D.
Dr. Margo Heath-Chiozzi, M.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
13.74K
+2.70%
Ms. Elizabeth Crowley
Ms. Elizabeth Crowley
Senior Vice President, Chief Product Development Officer
Senior Vice President, Chief Product Development Officer
9.07K
--
Dr. Tibor Keler, Ph.D.
Dr. Tibor Keler, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
7.36K
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Wellington Management Company, LLP
12.58%
Kynam Capital Management LP
9.79%
BlackRock Institutional Trust Company, N.A.
6.97%
Fidelity Management & Research Company LLC
5.85%
The Vanguard Group, Inc.
5.85%
Other
58.95%
持股股東
持股股東
佔比
Wellington Management Company, LLP
12.58%
Kynam Capital Management LP
9.79%
BlackRock Institutional Trust Company, N.A.
6.97%
Fidelity Management & Research Company LLC
5.85%
The Vanguard Group, Inc.
5.85%
Other
58.95%
股東類型
持股股東
佔比
Investment Advisor
45.68%
Hedge Fund
31.15%
Investment Advisor/Hedge Fund
29.65%
Research Firm
3.45%
Venture Capital
2.56%
Bank and Trust
0.33%
Pension Fund
0.31%
Individual Investor
0.27%
Insurance Company
0.04%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
419
75.39M
113.55%
-14.43M
2025Q1
437
75.31M
113.46%
-13.68M
2024Q4
437
75.05M
113.05%
-8.14M
2024Q3
429
73.28M
110.59%
-7.16M
2024Q2
432
71.48M
107.86%
-10.62M
2024Q1
419
71.32M
108.50%
+952.72K
2023Q4
406
62.72M
112.33%
-412.93K
2023Q3
403
52.10M
110.18%
-8.63M
2023Q2
410
51.84M
109.57%
-7.47M
2023Q1
419
51.38M
108.89%
-6.42M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wellington Management Company, LLP
8.35M
12.58%
-621.68K
-6.93%
Mar 31, 2025
Kynam Capital Management LP
6.50M
9.79%
+1.44M
+28.35%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.62M
6.97%
-29.87K
-0.64%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.89M
5.85%
+441.18K
+12.80%
Mar 31, 2025
The Vanguard Group, Inc.
3.89M
5.85%
+16.44K
+0.42%
Mar 31, 2025
Eventide Asset Management, LLC
3.75M
5.66%
+1.53K
+0.04%
Mar 31, 2025
T. Rowe Price Associates, Inc.
3.35M
5.05%
-144.43K
-4.13%
Mar 31, 2025
Commodore Capital LP
3.35M
5.05%
+150.00K
+4.69%
Apr 03, 2025
Bellevue Asset Management AG
3.07M
4.63%
--
--
Mar 31, 2025
State Street Global Advisors (US)
2.81M
4.23%
-428.60K
-13.25%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ALPS Medical Breakthroughs ETF
0.91%
Virtus LifeSci Biotech Clinical Trials ETF
0.9%
SPDR S&P Biotech ETF
0.37%
Direxion Daily S&P Biotech Bull 3X Shares
0.21%
Nuveen ESG Small-Cap ETF
0.11%
Fidelity Fundamental Small-Mid Cap ETF
0.11%
T Rowe Price Small-Mid Cap ETF
0.1%
iShares Russell 2000 Value ETF
0.1%
Avantis US Small Cap Equity ETF
0.09%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.07%
查看更多
ALPS Medical Breakthroughs ETF
佔比0.91%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.9%
SPDR S&P Biotech ETF
佔比0.37%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.21%
Nuveen ESG Small-Cap ETF
佔比0.11%
Fidelity Fundamental Small-Mid Cap ETF
佔比0.11%
T Rowe Price Small-Mid Cap ETF
佔比0.1%
iShares Russell 2000 Value ETF
佔比0.1%
Avantis US Small Cap Equity ETF
佔比0.09%
JPMorgan BetaBuilders US Small Cap Equity ETF
佔比0.07%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
